Tonghe Chemicals

Jiangxi Tonghe Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale production of chemical active pharmaceutical ingredients (APIs) and advanced intermediates. The company serves a global clientele, providing high-quality components for drugs targeting the central nervous system, cardiovascular system, and digestive tract. Key products in its portfolio include Gabapentin, Telmisartan, and Vonoprazan, manufactured in facilities that adhere to international cGMP standards. Tonghe Pharmaceutical is publicly traded on the Shenzhen Stock Exchange and is increasingly focusing on Contract Development and Manufacturing Organization (CDMO) services to support innovative drug developers. Its strategic focus remains on high-barrier, high-growth API markets and expanding its footprint in regulated markets like the US, EU, and Japan.